Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12271)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 14, 2020 (publication date) through Jul 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Amnekar RV, Khan SA, Rashid M, Khade B, Thorat R, Gera P, Shrikhande SV, Smoot DT, Ashktorab H, Gupta S. Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer. World J Gastroenterol 2020; 26(6): 598-613 [PMID: 32103870 DOI: 10.3748/wjg.v26.i6.598] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i6/598.htm |
| Number | Citing Articles |
| 1 |
Popat Mohite, Abhijeet Puri, Shubham Munde, Riteshkumar Patil, Sudarshan Singh. Biotechnology and Cancer Therapeutics. Interdisciplinary Biotechnological Advances 2025; : 205 doi: 10.1007/978-981-96-4959-4_7
|
| 2 |
Matteo Canale, Andrea Casadei-Gardini, Paola Ulivi, Maria Arechederra, Carmen Berasain, Pier-Luigi Lollini, Maite G. Fernández-Barrena, Matías A. Avila. Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities. International Journal of Molecular Sciences 2020; 21(15): 5500 doi: 10.3390/ijms21155500
|
| 3 |
Shabir Ahmad Ganai. Histone Deacetylase Inhibitors in Combinatorial Anticancer Therapy. 2020; : 203 doi: 10.1007/978-981-15-8179-3_10
|
| 4 |
Marina Leite, Raquel Seruca, Jorge M. Gonçalves. Hereditary Gastric and Breast Cancer Syndrome. 2023; : 281 doi: 10.1007/978-3-031-21317-5_20
|
| 5 |
Zhen Shi, Yazhen Wang, Yu Sun, Xueying Wu, Tianyuan Xiao, Shaobo Dong, Tianyu Lan. Facile One‐Pot Synthesis of Magnetic Targeted Polymers for Drug Delivery and Study on Thermal Decomposition Kinetics. ChemistrySelect 2021; 6(6): 1191 doi: 10.1002/slct.202004607
|
| 6 |
Moumita Saha, Shankar Gupta, Ashutosh Gupta, Rajiv Patel, Aditya Dev Rajora, Abdulrahman A. Almehizia, Hero Khan Pathan, Vivek Asati. Development of Novel Hydroxy Amide‐Based HDAC1 Inhibitors: Integrated Pharmacophore Modelling, 3D‐QSAR, and Virtual Screening Studies. ChemistrySelect 2024; 9(46) doi: 10.1002/slct.202404466
|
| 7 |
Jiaqi Tian, Miaomiao Han, Fuyang Song, Yun Liu, Yuhou Shen, Jiateng Zhong. Advances of HDAC inhibitors in tumor therapy: potential applications through immune modulation. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1576781
|
| 8 |
Fatima Ezzahra Bennani, Khalid Karrouchi, Latifa Doudach, Mario Scrima, Noor Rahman, Luca Rastrelli, Trina Ekawati Tallei, Christopher E. Rudd, My El Abbes Faouzi, M’hammed Ansar. In Silico Identification of Promising New Pyrazole Derivative-Based Small Molecules for Modulating CRMP2, C-RAF, CYP17, VEGFR, C-KIT, and HDAC—Application towards Cancer Therapeutics. Current Issues in Molecular Biology 2022; 44(11): 5312 doi: 10.3390/cimb44110361
|
| 9 |
Camilla Stephens, M Isabel Lucena, Raúl J Andrade. Reference Module in Biomedical Sciences. 2025; doi: 10.1016/B978-0-323-95488-4.00276-X
|
| 10 |
Xiuhong Wei, Bolian Xiao, Liying Wang, Lanlan Zang, Fengyuan Che. Potential new targets and drugs related to histone modifications in glioma treatment. Bioorganic Chemistry 2021; 112: 104942 doi: 10.1016/j.bioorg.2021.104942
|
| 11 |
Kanto Shozu, Syuzo Kaneko, Norio Shinkai, Ai Dozen, Hirofumi Kosuge, Makoto Nakakido, Hidenori Machino, Ken Takasawa, Ken Asada, Masaaki Komatsu, Kouhei Tsumoto, Shin-Ichi Ohnuma, Ryuji Hamamoto. Repression of the PRELP gene is relieved by histone deacetylase inhibitors through acetylation of histone H2B lysine 5 in bladder cancer. Clinical Epigenetics 2022; 14(1) doi: 10.1186/s13148-022-01370-z
|
| 12 |
Abhiram Natu, Aditi Pedgaonkar, Sanjay Gupta. Mitochondrial dysfunction and chromatin changes with autophagy-mediated survival in doxorubicin resistant cancer cell lines. Biochemical and Biophysical Research Communications 2023; 648: 1 doi: 10.1016/j.bbrc.2023.01.081
|
| 13 |
Jingjing Yang, Qingyang Liu, Xiawei Zhang, Yu Jing, Ning Le, Meng Li, Lingmin Xu, Weijia Zhao, Sai Huang, Daihong Liu, Liping Dou. A phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. International Immunopharmacology 2025; 151: 114268 doi: 10.1016/j.intimp.2025.114268
|
| 14 |
Huanran Sun, Jiaqi Song, Mingming Sun, Changliang Shan. Epigenetic Regulation in Overcoming Chemoresistance. 2021; : 25 doi: 10.1016/B978-0-12-823684-0.00014-1
|
| 15 |
Tamara Zenz, Robert Jenke, Denys Oliinyk, Sandra Noske, René Thieme, Tim Kahl, Ines Gockel, Florian Meier-Rosar, Achim Aigner, Thomas RH Büch. Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostat. Neoplasia 2025; 60: 101121 doi: 10.1016/j.neo.2024.101121
|
| 16 |
Abhiram Natu, Anjali Singh, Sanjay Gupta. Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities. World Journal of Hepatology 2021; 13(11): 1568-1583 doi: 10.4254/wjh.v13.i11.1568
|
| 17 |
Tatjana Lumpp, Sandra Stößer, Franziska Fischer, Andrea Hartwig, Beate Köberle. Role of Epigenetics for the Efficacy of Cisplatin. International Journal of Molecular Sciences 2024; 25(2): 1130 doi: 10.3390/ijms25021130
|
| 18 |
Róisín M. Cassidy, Sharon L. McKenna, Órla P. Barry. Evaluation of Cytotoxic Activity of Epigenetic Drugs in Oesophageal Squamous Cell Carcinoma. European Journal of Medical and Health Sciences 2023; 5(2): 25 doi: 10.24018/ejmed.2023.5.2.1618
|
| 19 |
Naveena A. N. Kumar, Anmi Jose, Nawaz Usman, Keshava Rajan, Murali Munisamy, Preethi S. Shetty, Mahadev Rao. Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges. Langenbeck's Archives of Surgery 2022; 407(1): 87 doi: 10.1007/s00423-021-02314-6
|
| 20 |
Paras Mani Giri, Ashish Kumar, Philip Salu, Venkatachalem Sathish, Katie Reindl, Sanku Mallik, Buddhadev Layek. Nanocarrier mediated entinostat and oxaliplatin combination therapy displayed enhanced efficacy against pancreatic cancer. Biomedicine & Pharmacotherapy 2024; 175: 116743 doi: 10.1016/j.biopha.2024.116743
|
| 21 |
Qiang Guo, Xin‐Yuan Wang, Yan‐Chang Zhai, Yong‐Wei Dong, Qing‐Si He. RETRACTED: Oxaliplatin activates P53/miR‐34a/survivin axis in inhibiting the progression of gastric cancer cells. Immunity, Inflammation and Disease 2024; 12(9) doi: 10.1002/iid3.70004
|
| 22 |
Ganji Purnachandra Nagaraju, Prameswari Kasa, Begum Dariya, Nagalakshmi Surepalli, Sujatha Peela, Sarfraz Ahmad. Epigenetics and therapeutic targets in gastrointestinal malignancies. Drug Discovery Today 2021; 26(10): 2303 doi: 10.1016/j.drudis.2021.04.013
|
| 23 |
Arshad Ali, Ayaz Ali, Shaker Khan, Muhammad Ibrahim, Mohammed Ali Alshehri, Anand Thirupathi. Inhibition of HDACs Suppresses Cell Proliferation and Cell Migration of Gastric Cancer by Regulating E2F5 Targeting BCL2. Life 2021; 11(12): 1425 doi: 10.3390/life11121425
|